DC
EW icon

Davenport & Co’s Edwards Lifesciences EW Stock Holding History

Davenport & Co’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361K Buy
+3,988
New +$334K ﹤0.01% 1127
2024
Q4 		– Sell
-3,031
Closed -$200K – 1169
2024
Q3 		$200K Buy
+3,031
New +$220K ﹤0.01% 1110
2024
Q1 		– Sell
-2,830
Closed -$216K – 1118
2023
Q4 		$216K Buy
+2,830
New +$197K ﹤0.01% 996
2023
Q3 		– Sell
-2,889
Closed -$273K – 1064
2023
Q2 		$273K Buy
2,889
+42
+1% +$3.65K ﹤0.01% 924
2023
Q1 		$236K Sell
2,847
-567
-17% -$44.6K ﹤0.01% 933
2022
Q4 		$255K Sell
3,414
-2,986
-47% -$230K ﹤0.01% 867
2022
Q3 		$529K Sell
6,400
-584
-8% -$56.2K ﹤0.01% 654
2022
Q2 		$664K Sell
6,984
-482
-6% -$49.9K 0.01% 599
2022
Q1 		$879K Buy
7,466
+416
+6% +$46.7K 0.01% 586
2021
Q4 		$913K Buy
7,050
+240
+4% +$28K 0.01% 589
2021
Q3 		$771K Buy
6,810
+442
+7% +$50.5K 0.01% 602
2021
Q2 		$660K Buy
6,368
+3,639
+133% +$343K 0.01% 573
2021
Q1 		$228K Sell
2,729
-400
-13% -$33.8K ﹤0.01% 730
2020
Q4 		$285K Hold
3,129
– – ﹤0.01% 654
2020
Q3 		$250K Sell
3,129
-846
-21% -$66K ﹤0.01% 625
2020
Q2 		$275K Sell
3,975
-75
-2% -$5.33K ﹤0.01% 569
2020
Q1 		$255K Sell
4,050
-468
-10% -$33.8K ﹤0.01% 531
2019
Q4 		$351K Sell
4,518
-282
-6% -$22K ﹤0.01% 552
2019
Q3 		$296K Hold
4,800
– – ﹤0.01% 565
2019
Q2 		$296K Hold
4,800
– – ﹤0.01% 569
2019
Q1 		$306K Sell
4,800
-90
-2% -$5.14K ﹤0.01% 533
2018
Q4 		$250K Sell
4,890
-300
-6% -$15.2K ﹤0.01% 552
2018
Q3 		$301K Buy
5,190
+210
+4% +$10.3K ﹤0.01% 551
2018
Q2 		$242K Buy
+4,980
New +$232K ﹤0.01% 606

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Davenport & Co's EW Position: Q2 2026 in Review

Davenport & Co opened a new position in Edwards Lifesciences (EW) in Q2 2026: 3,988 shares worth $361K. The stake represents ﹤0.01% of the portfolio and ranks #1127 among its holdings. This is a return to the name: Davenport & Co previously reported a position in EW as recently as Q3 2024.

Davenport & Co first reported a position in EW in Q2 2018 and has held it in 24 quarters since. The position peaked at $913K in Q4 2021. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Davenport & Co held 3,988 shares of Edwards Lifesciences worth $361K as of Q2 2026.
  • Edwards Lifesciences was a new Davenport & Co position in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Davenport & Co's portfolio in Q2 2026, its #1127 holding.
  • Davenport & Co first reported a position in Edwards Lifesciences in Q2 2018 and has held it in 24 quarters since.
  • Davenport & Co's Edwards Lifesciences position peaked at $913K in Q4 2021.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.